Mardil

About Mardil

Mardil Medical is a pioneering company in the field of cardiovascular therapies, focusing on the treatment of mitral valve regurgitation (FMR). The company serves patients primarily in the United States, where an estimated 4 million individuals suffer from significant FMR, particularly affecting those aged 75 and older. Mardil Medical's flagship product, the VenTouch System, targets the root cause of FMR through a simple, minimally invasive surgical procedure, offering a new standard in cardiovascular care.

The company operates within the medical device market, specifically targeting cardiovascular health. Its business model revolves around the development, manufacturing, and distribution of innovative medical devices designed to improve patient outcomes. Revenue is generated through the sale of these devices to hospitals, clinics, and healthcare providers who perform cardiovascular surgeries.

Mardil Medical's approach combines advanced technology with a deep understanding of cardiovascular diseases, aiming to provide effective and less invasive treatment options. By focusing on a specific and significant medical condition, the company positions itself as a leader in the niche market of mitral valve regurgitation therapies.